Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis

BACKGROUND: The efficacy and safety of 5α-reductase inhibitors (5ARIs) in treating prostate cancer (PCa) have not been fully determined. We performed a meta-analysis to evaluate the effectiveness and safety of 5ARIs for PCa patients. METHODS: A comprehensive literature search of online databases was...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Tuo, Lin, Xueming, Duan, Xiaolu, He, Zihao, Zhao, Zhijian, Zeng, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271889/
https://www.ncbi.nlm.nih.gov/pubmed/32547884
http://dx.doi.org/10.7717/peerj.9282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271889/
https://www.ncbi.nlm.nih.gov/pubmed/32547884
http://dx.doi.org/10.7717/peerj.9282

Ejemplares similares